These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23225107)

  • 1. Milan criteria, multi-nodularity, and microvascular invasion predict the recurrence patterns of hepatocellular carcinoma after resection.
    Hung HH; Lei HJ; Chau GY; Su CW; Hsia CY; Kao WY; Lui WY; Wu WC; Lin HC; Wu JC
    J Gastrointest Surg; 2013 Apr; 17(4):702-11. PubMed ID: 23225107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microvascular invasion is a better predictor of tumor recurrence and overall survival following surgical resection for hepatocellular carcinoma compared to the Milan criteria.
    Lim KC; Chow PK; Allen JC; Chia GS; Lim M; Cheow PC; Chung AY; Ooi LL; Tan SB
    Ann Surg; 2011 Jul; 254(1):108-13. PubMed ID: 21527845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation.
    Löhe F; Angele MK; Rentsch M; Graeb C; Gerbes A; Löhrs U; Beuers U; Jauch KW
    Clin Transplant; 2007; 21(6):696-701. PubMed ID: 17988261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
    Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria.
    Cha DI; Kang TW; Jeong WK; Kim JM; Choi GS; Joh JW; Yi NJ; Ahn SH
    Eur Radiol; 2024 Jan; 34(1):498-508. PubMed ID: 37505248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association of microvascular invasion with recurrence and prognosis of patients with small hepatocellular carcinoma undergoing liver transplantation].
    Zhu YB; Xu X; Zheng SS
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 43(6):658-63. PubMed ID: 25644564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Brazilian expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a multicenter study.
    Chagas AL; Mattos AA; Diniz MA; Felga GEG; Boin IFSF; Silva RCMA; Silva RF; Garcia JHP; Lima AS; Coelho JCU; Bittencourt PL; Alves VAF; D'Albuquerque LAC; Carrilho FJ;
    Ann Hepatol; 2021; 22():100294. PubMed ID: 33276136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence beyond the Milan criteria after curative-intent resection of hepatocellular carcinoma: A novel tumor-burden based prediction model.
    Tsilimigras DI; Mehta R; Guglielmi A; Ratti F; Marques HP; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Hugh T; Aldrighetti L; Endo I; Pawlik TM
    J Surg Oncol; 2020 Oct; 122(5):955-963. PubMed ID: 32602143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients with early recurrence of hepatocellular carcinoma have poor prognosis.
    Kobayashi T; Aikata H; Kobayashi T; Ohdan H; Arihiro K; Chayama K
    Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):279-288. PubMed ID: 28603096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Resection: Validation of a Clinical Risk Score in an International Cohort.
    Zheng J; Chou JF; Gönen M; Vachharajani N; Chapman WC; Majella Doyle MB; Turcotte S; Vandenbroucke-Menu F; Lapointe R; Buettner S; Groot Koerkamp B; Ijzermans JNM; Chan CY; Goh BKP; Teo JY; Kam JH; Jeyaraj PR; Cheow PC; Chung AYF; Chow PKH; Ooi LLPJ; Balachandran VP; Kingham TP; Allen PJ; D'Angelica MI; DeMatteo RP; Jarnagin WR; Lee SY
    Ann Surg; 2017 Oct; 266(4):693-701. PubMed ID: 28650354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria.
    Tsilimigras DI; Mehta R; Paredes AZ; Moris D; Sahara K; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Spolverato G; Umberto C; Pawlik TM
    Ann Surg; 2020 Oct; 272(4):574-581. PubMed ID: 32932309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection.
    Eguchi S; Takatsuki M; Hidaka M; Soyama A; Tomonaga T; Muraoka I; Kanematsu T
    World J Surg; 2010 May; 34(5):1034-8. PubMed ID: 20127241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
    Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
    J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-Fetoprotein Slope >7.5 ng/mL per Month Predicts Microvascular Invasion and Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma.
    Giard JM; Mehta N; Dodge JL; Roberts JP; Yao FY
    Transplantation; 2018 May; 102(5):816-822. PubMed ID: 29505494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma.
    Kim JM; Joh JW; Yi NJ; Choi GS; Kim K; Lee KW; Suh KS
    J Gastrointest Surg; 2020 Oct; 24(10):2219-2227. PubMed ID: 31482410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-fetoprotein-adjusted-to-HCC-size criteria are associated with favourable survival after liver transplantation for hepatocellular carcinoma.
    Meischl T; Rasoul-Rockenschaub S; Győri G; Scheiner B; Trauner M; Soliman T; Berlakovich G; Pinter M
    United European Gastroenterol J; 2021 Mar; 9(2):209-219. PubMed ID: 32741316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
    Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
    Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.